


Healthcare Industry NewsFeed
HSMN NewsFeed - 22 May 2014
iRhythm Secures $17 Million in Funding Led by Novo A/S as Company Sees Record Growth for Its ZIO(R) Service
iRhythm Secures $17 Million in Funding Led by Novo A/S as Company Sees Record Growth for Its ZIO(R) Service
HSMN NewsFeed - 22 May 2014
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
HSMN NewsFeed - 21 May 2014
ReliantHeart's HeartAssist5(R) Achieves European CE Mark, Which Includes True Flow Remote Monitoring
ReliantHeart's HeartAssist5(R) Achieves European CE Mark, Which Includes True Flow Remote Monitoring
HSMN NewsFeed - 21 May 2014
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
HSMN NewsFeed - 21 May 2014
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 20 May 2014
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
HSMN NewsFeed - 20 May 2014
Edwards Lifesciences, Medtronic Agree to Global Transcatheter Valve Litigation Settlement
Edwards Lifesciences, Medtronic Agree to Global Transcatheter Valve Litigation Settlement
HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
HSMN NewsFeed - 19 May 2014
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
HSMN NewsFeed - 15 May 2014
Sorbent Therapeutics Closes First Tranche Of $15 Million Series D Financing
Sorbent Therapeutics Closes First Tranche Of $15 Million Series D Financing
HSMN NewsFeed - 15 May 2014
Boston Scientific Announces Definitive Agreement To Acquire Interventional Division Of Bayer AG
Boston Scientific Announces Definitive Agreement To Acquire Interventional Division Of Bayer AG
HSMN NewsFeed - 15 May 2014
Mylan Applauds Court's Ruling Dismissing Teva's Suit Against FDA on Copaxone(R)
Mylan Applauds Court's Ruling Dismissing Teva's Suit Against FDA on Copaxone(R)
HSMN NewsFeed - 14 May 2014
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
HSMN NewsFeed - 14 May 2014
POZEN Announces U.S. Rights for Treximet(R) to Be Acquired by Pernix Therapeutics
POZEN Announces U.S. Rights for Treximet(R) to Be Acquired by Pernix Therapeutics
HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
HSMN NewsFeed - 13 May 2014
ClearSpec LLC Signs Distribution Agreement with McKesson Medical-Surgical
ClearSpec LLC Signs Distribution Agreement with McKesson Medical-Surgical
HSMN NewsFeed - 12 May 2014
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs
